Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.94 USD | +0.19% | +0.53% | +240.71% |
05-10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
05-09 | MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+240.71% | 4.25B | |
+3.91% | 108B | |
+10.87% | 104B | |
+1.28% | 22.33B | |
-13.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.66% | 17.64B | |
+3.75% | 14.05B | |
+36.70% | 12.51B |
- Stock Market
- Equities
- ALPN Stock
- News Alpine Immune Sciences, Inc.
- Wolfe Research Initiates Alpine Immune Sciences With Outperform Rating, $44 Price Target